Search Weight Loss Topics:

Page 517«..1020..516517518519..530540..»

This Handy Chart Is Your Ultimate Guide to Drinking On the Keto Diet – Yahoo Lifestyle

Posted: September 21, 2020 at 3:54 pm

Photo credit: Alex Tihonovs / EyeEm - Getty Images

From Men's Health

It's a new year and chances are you're trying out a new way of eating. And since it's 2020, chances are that new way of eating is the keto diet. Despite the fact that you can eat bacon, burgers, and eggs as often as you want, you might find yourself missing things like pasta, bread, and BOOZE. Yes, drinking on the keto diet is tough, but not impossible. That's why we created this handy chart to guide you on your journey trying to have a social life while keeping keto.

Though it's worth noting that you should probably be restricting your drinking on any diet, especially the keto diet, which relies on you staying in the delicate balance of ketosis, everyone deserves to let loose every once in a while. We created this chart so you can get your drink on responsibly with some low-carb alcohols.

All of our carb amounts come via the United States Department of Agriculture's database, which is really helpful if you're monitoring pretty much any kind of nutritional info.

You should consult the chart for full details, but here are some good keto rules of thumb to keep in mind: Stick to dry wines in general. They'll pretty much always be lower-carb. Don't mess with sugary mixers, as drinking straight liquor or mixing with soda water will always be lower-carb. Finally, many spiked seltzers can be choices, but be sure to check the label to make sure as there are so many brands out there.

You Might Also Like

Link:
This Handy Chart Is Your Ultimate Guide to Drinking On the Keto Diet - Yahoo Lifestyle

Eczema treatment: Eliminating this from your diet may lead to skin improvements – Express

Posted: September 21, 2020 at 3:54 pm

Eczema is a general term for itchy, dry skin conditions and the most common is atopic eczema, also known as atopic dermatitis. According to the NHS, atopic eczema causes the skin to become itchy, dry, cracked and sore. "Some people only have small patches of dry skin, but others may experience widespread inflamed skin all over the body," explains the health body.

White flour products give a lighter texture to muffins, cakes and cookies and a flakier crust to pies and pastries, according to medical website LiveStrong.

"Also called refined flour, white flour has had many of its nutrients and most of its fibre removed during processing, the health body said.

The survey also found that people reported improvements in their skin when excluding gluten and nightshades.

Potatoes, tomatoes, peppers, and eggplants are all common nightshades.

"It may not be healthy to cut these foods from your diet, especially in young children who need the calcium, calories and protein from these foods," says the health body.

As it explains, if a GP suspects a food allergy, you may be referred to a dietitian (a specialist in diet and nutrition).

They can help to work out a way to avoid the food you're allergic to while ensuring you still get all the nutrition you need.

Alternatively, you may be referred to a hospital specialist, such as an immunologist, dermatologist or paediatrician, adds the NHS.

More here:
Eczema treatment: Eliminating this from your diet may lead to skin improvements - Express

Masaba Gupta reveals the pros of 16-hour fast and cons of Keto diet in dealing with PCOD – Hindustan Times

Posted: September 21, 2020 at 3:54 pm

If there is one major ailment that has taken the world of women by storm, it has to be Polycystic Ovarian Disease or PCOD which strikes mostly at an early age and makes a substantial number of young adults suffer including fashion designer Masaba Gupta. Currently making heads turn with her stellar performance in Netflix series Masaba Masaba, the ace designer shared health tips with fans on how to make PCOD vanish.

Taking to her Instagram handle, the diva answered on a question answer round with fans about how her daily 16-hour fast not only makes her feel great but also gives her more energy, more clarity and no acidity. My pcod etc has nearly vanished! (sic), she replied to a fan who had asked Are you doing the 16 hour fast everyday? How do you feel? (sic).

When another fan asked, How do you deal with PCOD? I have PCOD for 7 years now and it just gets worse, Masaba spilled some handy tips that also included the cons of Keto diet. She shared, Lose weight!! Its the best way! But pls do it in a safe & slow way. She added, Do not get on some crap fad diet especially Keto it messed my body up.

She concluded by advising, Speak to a nutritionist- eat ghar ka khaana. Workout 6 days a week. Stay happy. Bas (sic) and punctuated it with a red heart emoji.

Three main symptoms of PCOD in women include high androgen levels, irregular periods, and cysts in the ovaries. To confirm the diagnosis, doctors conduct a pelvic exam, blood tests and ultrasound as it is a condition developed by the imbalance of hormones.

While there is no permanent cure for PCOD, the symptoms can be managed with the intake of right diet of limiting carbohydrates, maintaining a healthy weight and with adequate exercise. Blood sugar levels can be lowered with exercise and since weight loss can reduce insulin and androgen levels, it may restore ovulation and can even help with infertility. However, as Masaba warned no Keto and weight loss only in a safe slow way.

Follow more stories on Facebook and Twitter

More here:
Masaba Gupta reveals the pros of 16-hour fast and cons of Keto diet in dealing with PCOD - Hindustan Times

Keto diet could reduce the risk of Alzheimer’s disease – India New England

Posted: September 21, 2020 at 3:54 pm

Hyderabad Eating healthy, low calorie food could help fight the fungi in the gut and thus reduce the risk of dementia among senior citizens, doctors said, citing a new study done in the US that revealed that the diet has a direct connection with Alzheimers disease.

The findings of the recent study by scientists at the Wake Forest School of Medicine are significant as health experts are looking at possible therapies to address the grave problem.

The Alzheimers Association, a global body for dementia, reported that mild cognitive impairment (MCI) is witnessed among at least 15-20 per cent people aged over 65 years, which impacts the ability to think and can lead to Alzheimers disease.

The new research suggests that ketogenic diet alters the bacterial communities in the human gut and helps reduce biomarkers of Alzheimers disease among those suffering from MCI.

In our conservative society, dementia often impacts social and family relations, including reduction in work hours, loss of employment, relationships ending, and even the need to relocate or change living arrangements arises. It is often noticed that such problems lead victims to becoming unwanted in the family and social setting. Possible solutions to prevent this problem are being researched for decades, and this new study provides a glimpse of hope, said Dr Simanchal Mishra, Senior Consultant Neuro Physician, Medicover Hospitals.

There is now a possible preventive mechanism through which the risk of Alzheimers can be reduced to a great extent, and the suggested solution appears to be an easily manageable one, he added.

Alzheimers is an irreversible dementia. There are many other causes of dementia which are preventable or reversible. Early diagnosis and treatment of dementia can help make the disease reversible. Literacy/ knowledge of the ailment is one of the most important factors in preventing Alzheimers disease, said Dr M.K. Singh, Senior Consultant Neurologist, Continental Hospitals.

While quitting smoking and alcohol, eating healthy diet, exercising for at least 150 minutes a week are suggested as steps to prevent Alzheimers disease, the new research reveals that lower calories food forces a human body to conserve energy, and this leads to drop in body temperature, and this too helps in preventing dementia. Additionally, reading, writing, learning new languages and/or musical instruments, maintaining an active social life are highly recommended to ensure Alzheimers is kept at bay, he said.

Conditions like high blood pressure, high cholesterol, and diabetes, which are known to increase the risk of cardiovascular diseases, also increase the risk of developing Alzheimers among ageing population. Hence, in addition to leading an active life, cutting down on calories in food is surely a great way to stay happy and remember everything till the end of life. (IANS)

See the rest here:
Keto diet could reduce the risk of Alzheimer's disease - India New England

COVID-19 Update: Global Ayurvedic Diet and Medicines Market is Expected to Grow at a Healthy CAGR with Top players: Botique, Herbal Hills, Basic…

Posted: September 21, 2020 at 3:54 pm

Global Ayurvedic Diet and Medicines Market 2020 research report presents analysis of market size, share, and growth, trends, cost structure, statistical and comprehensive data of the global market. Research reports analyses the major opportunities, CAGR, yearly growth rates to help the readers to understand the qualitative and quantitative aspects of theGlobal Ayurvedic Diet and MedicinesMarket. The competition landscape, company overview, financials, recent developments and long-term investments related to theGlobal Ayurvedic Diet and Medicines Marketare mentioned in this report.

The key segments covered in this report are geographical segments, end-use/application segments, and competitor segments. The local segment, regional supply, application, and wise demand, major players, prices are also available by 2025. Global Ayurvedic Diet and Medicines Market are mentioned in the competition landscape, company overview, financials, recent developments and long-term investments.

Get PDF Sample Copy of the Report (Including Full TOC, List of Tables & Figures, Chart):https://www.marketinforeports.com/Market-Reports/Request-Sample/155146

Top Key players profiled in the Ayurvedic Diet and Medicines market report include:Botique, Herbal Hills, Basic Ayurveda, Natreon, Emami Group, Dabur, Baidyanalh, Shahnaz Husain Group, Himalaya Drug, Ke and More

Market segmentation, by product types:DietMedicinesMarket segmentation, by applications:WomenMen

global Ayurvedic Diet and Medicines market report also highlights key insights on the factors that drive the growth of the market as well as key challenges that are required to Ayurvedic Diet and Medicines market growth in the projection period. Here provide the perspectives for the impact of COVID-19 from the long and short term. Ayurvedic Diet and Medicines market contain the influence of the crisis on the industry chain, especially for marketing channels. Update the industry economic revitalization plan of the country-wise government.

To Understand the influence of COVID-19 on the Set Screw Market with our analysts monitoring the situation across the globe. Get here sample analysis

Other Important Key Points of Ayurvedic Diet and Medicines Market:

Years considered for this report:

Key questions answered in this report:

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketinforeports.com/Market-Reports/Request_discount/155146

Key point summary of the Global Ayurvedic Diet and Medicines Market report:

Detailed TOC of Ayurvedic Diet and Medicines Market Report 2020-2025:

Chapter 1 Ayurvedic Diet and Medicines Market Overview

Chapter 2 Economic Impact on Industry

Chapter 3 Market Competition by Manufacturers

Chapter 4 Production, Revenue (Value) by Region

Chapter 5 Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Production, Revenue (Value), Price Trend by Type

Chapter 7 Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Ayurvedic Diet and Medicines Market Forecast

Continued

For More Information with full TOC: https://www.marketinforeports.com/Market-Reports/155146/Ayurvedic-Diet-and-Medicines-market

Customization of the Report:Market Info Reports provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Get Customization of the [emailprotected]:https://www.marketinforeports.com/Market-Reports/Request-Customization/155146/Ayurvedic-Diet-and-Medicines-market

Get in Touch with Us :Mr. Marcus KelCall: +1 915 229 3004 (U.S)+44 7452 242832 (U.K)Email: s[emailprotected]Website: http://www.marketinforeports.com

View original post here:
COVID-19 Update: Global Ayurvedic Diet and Medicines Market is Expected to Grow at a Healthy CAGR with Top players: Botique, Herbal Hills, Basic...

A Bipartisan Bill Would Regulate Hemp CBD As A Dietary Supplement – The Fresh Toast

Posted: September 21, 2020 at 3:54 pm

Last week, Oregon Representative Kurt Schrader (D) and Virginia Representative Morgan Griffith (R) introducedThe Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020(H.R. 8179). If enacted in its current form, H.R. 8179 would legalize the manufacture, sale and marketing of hemp, hemp-derived cannabidiol and other hemp extracts (collectively referred to as Hemp Products) as dietary supplements under the Federal Food, Drug and Cosmetic Act (FDCA).

This means that these products would be exempt from the FDCAs Drug Exclusion Rule, which, as we previously discussed, currently prevents the sale and marketing of any substance that has been approved or investigated by the FDA as a new drug as a conventional food or dietary supplement In July 2018, the FDA approved CBD as a drug ingredient inEpidiolex.

To be compliant with the FDCA, these Hemp Products would need to meet the existing regulatory framework imposed on dietary supplements. This comprehensive regulatory framework mandates, in part, that these products be safe as well as properly labeled and marketed.

Because Hemp Products were not sold and marketed in the U.S. as dietary supplements or conventional foods before October 15, 1994, they would be deemed new dietary ingredients or NDIs.

Pursuant to Section 413 of the FDCA, if a dietary supplement contains an NDI, its manufacturer and distributor must ensure that the NDI is adequately substantiated as being safe and must notify the FDA about that ingredientpriorto marketing.

RELATED: FDA Guidance On Cannabis Research: A Glimpse Of Whats To Come For CBD Products?

To meet this standard, manufacturers and distributor of Hemp Products would have to provide the FDA with information that is the basis on which they have concluded that their Hemp Products are reasonably expected to be safe under the conditions recommended or suggested in the labeling.

Photo by athima tongloom/Getty Images

If the manufacturers or distributors were to receive a no-objection letter from the FDA, or no response at all, they could lawfully market their Hemp Products after the 75-day notification period is over, assuming there is in fact a history of use or other evidence of safety establishing that the Hemp Products, when used under the conditions recommended or suggested in the labeling, are reasonably expected to be safe.

When it comes to labeling requirements, manufacturers and distributors of Hemp Products would need to ensure their product packaging contains specificlabeling elements, such as an identity statement and a nutrition facts panel and containno medical claimsabout the therapeutic values of their products. Inclusion of medical claims would suggest that the Hemp Products intended use is that of a drug, and thus, would violate the FDCA and warrantFDA and Federal Trade Commission(FTC) enforcement actions.

RELATED: DEA Interim Final Rule: What Is Synthetically Derived THC?

In sum, the enactment of H.R. 8179 would help alleviate regulatory uncertainties surrounding the legality of Hemp Products, which have hindered market opportunities for hemp farmers and businesses. In addition, the passage of this bipartisan bill would help raise the quality and safety of Hemp Products, and thus, protect consumers.

If, like aconsensusof hemp stakeholders, you support H.R. 8129, you should contact your representatives and urge them to co-sponsor this bill. For automatically generated messages, visit the U.S. Hemp Rountables onlineAction Center.

Nathalie Bougeniesis an attorney atHarris Bricken. This article wasoriginally published on theCanna Law Blog and is reposted with permission.

More:
A Bipartisan Bill Would Regulate Hemp CBD As A Dietary Supplement - The Fresh Toast

Keto Diet Market| Insights on the Crisis and the Roadmap to Recovery from COVID-19 Pandemic| Technavio – Yahoo Finance

Posted: September 21, 2020 at 3:54 pm

TipRanks

Is more volatility on tap for stocks? Following a three-week losing streak, the longest in about a year, all eyes are on the market. The three major U.S. stock indexes have struggled for the last few weeks as the titans of tech, which have fueled the charge forward from COVID-induced lows, came under pressure due to overheated valuations, with market watchers waiting to see how renewed lockdown fears will come into play.So, whats the bottom line for investors? Even though uncertainty remains as Wall Street gears up for the fourth quarter, the pros are pounding the table on a select few names, noting that these tickers boast strong long-term growth narratives.Bearing this in mind, our focus shifted to two penny stocks backed by investment firm Cantor. Major gains could be in store, as the firms analysts believe these tickers trading for less than $5 per share could climb all the way to $11.These plays are known for being risky, so we turned to TipRanks database. Using the platform, we got the full scoop, to find out why both are so compelling even with the risk involved.Rockwell Medical (RMTI)With the goal of transforming iron deficiency and anemia management in a wide variety of therapeutic areas, Rockwell Medical works to improve the lives of patients all over the world. Given the strength of its technology and its $1.22 share price, Cantor thinks that now is the time to snap up shares.Firm analyst Brandon Folkes notes that RMTI has begun to build on its presence in the dialysis market with the recent launch of dialysate Triferic, which is the first and only FDA-approved treatment for the replacement of iron to maintain hemoglobin in adult patients with hemodialysis-dependent chronic kidney disease. This formulation is administered through the dialysate (mixed with liquid bicarbonate).On top of this, an IV formulation of Triferic (Triferic Avnu) will enter clinical evaluation in Q3 2020, with Folkes expecting the commercial release to come in the following quarter. Folkes said, The company continues to believe in the future of Triferic, dialysate and IV formulations, and is executing on its commercial strategy, which takes time to get adoption. Speaking to this commercial strategy, RMTI is offering three-month evaluation periods for Triferic and has converted 75% of clinics who completed the evaluation period. RMTI is also positioning Triferic at a price that results in a cost neutral position for the clinics, while receiving the clinical benefits from Triferic.Additionally, the company is set to hold a virtual investor meeting this month to discuss the opportunity for two new indications, total parental nutrition (TPN) and hospitalized acute decompensated congestive heart failure (CHF)....we believe this incremental information is a meaningful positive, as while RMTI had previously noted its indication in exploring additional indications, investors will now have a concrete map of the development work the company will employ to fully maximize the platform within a product potential of the Triferic platform, Folkes stated.If that wasnt enough, on September 9, RMTI announced that it has entered into an exclusive license agreement with Jeil Pharmaceutical for the rights to commercialize Triferic in South Korea. As per the terms of the agreement, RMTI will receive an upfront fee and is eligible for milestone payments and royalties on net sales.All of the above prompted Folkes to comment, We believe Triferic is an innovative product that will drive significant value for RMTI shareholders. We expect product approvals and upward earnings revisions in our DCF model to drive RMTI's stock higher.To this end, Folkes rates RMTI an Overweight (i.e. Buy) along with an $11 price target. Should the target be met, a twelve-month gain in the shape of a whopping 801% could be in store. (To watch Folkes track record, click here)Turning now to the rest of the Street, 2 Buys and no Holds or Sells have been published in the last three months. Therefore, RMTI has a Moderate Buy consensus rating. Based on the $10 average price target, shares could soar 719% in the next year. (See RMTI stock analysis on TipRanks)Taiwan Liposome Company (TLC)Using its LipAD lipid-assembled delivery system to enable sustained release and targeted deliveries that reduce toxicity and improve efficacy, Taiwan Liposome Company develops cutting-edge nanomedicines. Currently going for $4.38 apiece, Cantor views TLC as an under-the-radar story and believes its share price reflects an attractive entry point.Writing for the firm, analyst Kristen Kluska told clients, TLC is underappreciated considering the management has an extensive track record in liposomal products (including two acquisitions). She cites the company's two late-stage development programs, TLC599 (its BioSeizer formulation of dexamethasone sodium phosphate (DSP) designed to provide relief for knee osteoarthritis (OA) pain) and TLC590 (its therapy for post-surgical pain), that could present with advantages over current standard of care extended release products, in large markets.According to Kluska, the company remains on track to complete enrollment for the Phase 3 study of TLC599 by YE20. Further, TLC believes this program is superior to the competition as its possible to receive one injection every six months and show that repeated dosing is both safe and effective.Kluska added, Further, TLC599 consists of just one vial, which could allow for a quick preparation, whereas Zilretta has two vials, thus a potentially longer preparation time. The company also has flexibility with the needle size that could be used for this product, and believes there could be a potential utilization in the joints, hip, shoulder, etc., which the company could consider evaluating in the future. To this end, should the results be positive, the company could submit an NDA during 1H22.When it comes to TLC590, TLC already reported topline results from the Phase 2 post-surgical pain following bunionectomy study earlier this summer, arguing the candidate has a faster onset and a longer duration than other therapies. Now, management needs to meet with the FDA to discuss pivotal trial designs. As a reminder, TLC is evaluating a different API (ropivacaine) vs. competitors, which could potentially show a stronger safety profile. The company also believes this product could have lower COGS, which could allow for attracting pricing, Kluska pointed out.If that wasnt enough, TLC recently revealed it is evaluating a NanoX sustained release of hydroxychloroquine (HCQ) inhalation for prophylaxis and treatment of COVID-19. It already submitted an IND, and could be ready to initiate a Phase 1 study after approval, with data potentially coming by early 2021. It should be noted that Taiwan is the second largest API producer for HCQ in the world, so the company has clear access, in Kluskas opinion.It should come as no surprise, then, that Kluska stays with the bulls. The analyst rates TLC an Overweight (i.e. Buy) along with an $11 price target. Should her thesis play out, a potential twelve-month gain of 154% could be in the cards. (To watch Kluskas track record, click here)What does the rest of the Street have to say? With 2 Buys and zero Holds or Sells, the word on the Street is that TLC is a Moderate Buy. In addition, the $11 average price target matches Kluskas. (See TLC stock analysis on TipRanks)To find good ideas for penny stocks trading at attractive valuations, visit TipRanks Best Stocks to Buy, a newly launched tool that unites all of TipRanks equity insights.Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

Original post:
Keto Diet Market| Insights on the Crisis and the Roadmap to Recovery from COVID-19 Pandemic| Technavio - Yahoo Finance

Global Testosterone Replacement Therapy Market 2020 Trends Analysis and Coronavirus (COVID-19) Effect Analysis | Key Players Market With COVID-19…

Posted: September 21, 2020 at 3:52 pm

Global Testosterone Replacement Therapy Market 2020: Business Growth Rate, Manufacturing Analysis, Size, Share, Cost Structure, and Forecast to 2026

The Market Data Analytics published a recent report on the globalTestosterone Replacement Therapy market, which was studied by the research analysts for months. The report includes information from trusted primary and secondary resources along with detailed examination from the research analysts. Based on the analysis, research analysts have concluded that the global demand for the global Testosterone Replacement Therapy market was USD XX Million in 2019 and is anticipated to reach USD XX Million by the end of 2026. The expected CAGR for the market is around XX%.

Ask for a Sample Copy of the Report (Use Corporate email ID to Get Higher Priority):https://www.marketdataanalytics.biz/global-testosterone-replacement-therapy-market-20202027-by-player-41201.html#request-sample

Final Report will add the analysis of the impact of COVID-19 on this Industry.

The other factors that the report delivers is the revenue estimations, sales volume, industry size, and other important aspects, which includes market segmentation, growth factors, restraints, opportunities, challenges, and the market players.

The global Testosterone Replacement Therapy market incorporates information such as the basic overview of the industry, which includes definition, segmentation, and the industry structure. The global Testosterone Replacement Therapy market is segmented on the basis of{Gels, Injections, Patches, Other}; {Hospitals, Clinics, Others}. Along with this the product types and the applications of the Testosterone Replacement Therapy market are also discussed. Other data that is provided includes developmental trends, regional analysis of the Testosterone Replacement Therapy market, and the technological advancements. The developmental policies that have been updated are all discussed in the report.

Browse Full Report with More Professional and Technical Insights Including COVID-19 Impact@https://www.marketdataanalytics.biz/global-testosterone-replacement-therapy-market-20202027-by-player-41201.html

Some of the top most key players that are enlisted in the report areAbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva, Mylan, Upsher-Smith, Ferring Pharmaceuticals, Kyowa Kirin, Acerus Pharmaceuticals. The details that are represented in the report includes the cost structures, manufacturing process methodology, import and export consumption, supply and demand patterns, gross margins, recent developments made in the business, revenue analysis, and gross margins.

The report offers a comprehensive understanding of market dynamics across key regions, namely North America (United States, Canada and Mexico), Europe (Germany, France, United Kingdom, Russia and Italy), Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia), Latin America (Brazil, Argentina), and the Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa).

Contact Us For More Inquiry of Testosterone Replacement Therapy Report at::https://www.marketdataanalytics.biz/global-testosterone-replacement-therapy-market-20202027-by-player-41201.html#inquiry-for-buying

Key Questions Answered In The Report:

What is the growth potential of the global Testosterone Replacement Therapy market? Which regional market will emerge as a frontrunner during the forecast period 2020-2026? Which application segment will grow at a robust rate? What are the growth opportunities that may emerge in the industry in the years to come? What are the key challenges that the global market may face in the future? Which are the main companies in the global Testosterone Replacement Therapy market? Which are the growth strategies considered by the players to sustain hold in the global market?

Why Go For Market Data Analytics Research?

Market Data Analytics is a leading global market research and consulting firm. We focus on business consulting, industrial chain research, and consumer research to help customers provide non-linear revenue models. We believe that quality is the soul of the business and that is why we always strive for high quality products. Over the years, with our efforts and support from customers, we have collected inventive design methods in various high-quality market research and research teams with extensive experience.

See the original post:
Global Testosterone Replacement Therapy Market 2020 Trends Analysis and Coronavirus (COVID-19) Effect Analysis | Key Players Market With COVID-19...

Testosterone Replacement Therapy Market Growth Analysis with Top Players Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International…

Posted: September 21, 2020 at 3:52 pm

GlobalTestosterone Replacement Therapy MarketResearch Report is a resource, which provides current as well as upcoming technical and financial details of the industry to 2027. This report gives you so important and essentials data of Market size, share, trends, Growth, applications, forecast and cost analysis. Delivery development in North America, China, Europe, and South East Asia, Japan as well as in the Globe. The report proves to be indispensable when it comes to market definition, classifications, applications and engagements.

The market report also computes the market size and revenue generated from the sales. The industry analysis report presents the key statistics on the market status of global and regional manufacturers and also acts as a valuable source of leadership and direction. What is more, the Testosterone Replacement Therapy market report analyses and provides historic data along with the current performance of the market.

Get a Free Sample Copy of the Testosterone Replacement Therapy Market Report with Latest Industry Trends @https://www.coherentmarketinsights.com/insight/request-sample/2024

Global Testosterone Replacement Therapy Market competition by Top Key Players: AbbVie, Inc., Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International plc, Pfizer, Inc., Acerus Pharmaceuticals Corporation, and Perrigo Company plc.

Testosterone Replacement Therapy Market section by Region:

Segmentation: The report has been separated into different categories, such as product type, application, end user, and region. Every segment is evaluated based on the CAGR, share and growth potential. In the regional analysis, the report highlights the prospective region, which should generate opportunities in the global Testosterone Replacement Therapy market in the years to come. This segmented analysis will surely prove to be a useful tool for readers, stakeholders and market participants to get a full picture of the Testosterone Replacement Therapy global market and its growth potential in the years to come.

The Testosterone Replacement Therapy Market report offers a plethora of insights which include:

Changing consumption patterns among individuals globally.

Historical and future progress of the global Testosterone Replacement Therapy market.

Region-wise and country-wise segmentation of the Testosterone Replacement Therapy market to understand the revenue, and growth lookout in these areas.

Accurate Year-on-Year growth of the global Testosterone Replacement Therapy market.

Important trends, including proprietary technologies, ecological conservation, and globalization affecting the global Testosterone Replacement Therapy market.

Need a discount?

Note: *The discount is offered on the Standard Price of the report.

To get Incredible Discounts on this Premium Report, Click Here @https://www.coherentmarketinsights.com/insight/request-discount/2024

Important Information that can be extracted from the Report:

Assessment of the COVID-19 impact on the growth of the Testosterone Replacement Therapy Market

Successful market entry strategies formulated by emerging market players

Pricing and marketing strategies adopted by established market players

Country-wise assessment of the Testosterone Replacement Therapy Market in key regions

Year-on-Year growth of each market segment over the forecast period 2026

The Testosterone Replacement Therapy Market report considers the following years to predict market growth:

Historic Year: 2014 2018

Base Year: 2019

Estimated Year: 2020

Forecast Year: 2020 2027

The Global Testosterone Replacement Therapy Market is displayed in 13 Chapters:

Chapter 1: Market Overview, Drivers, Restraints and Opportunities

Chapter 2: Market Competition by Manufacturers

Chapter 3: Production by Regions

Chapter 4: Consumption by Regions

Chapter 5: Production, By Types, Revenue and Market share by Types

Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications

Chapter 7: Complete profiling and analysis of Manufacturers

Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses

Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10: Marketing Strategy Analysis, Distributors/Traders

Chapter 11: Market Effect Factors Analysis

Chapter 12: Market Forecast

Chapter 13: Testosterone Replacement Therapy Research Findings and Conclusion, Appendix, methodology and data source

Have Any Query? Ask Our Expert @ https://www.coherentmarketinsights.com/insight/request-customization/2024

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia or Oceania [Australia and New Zealand].

Contacts Us:

Mr. ShahCoherent Market Insights,1001 4th Ave,#3200 Seattle, WA 98154, U.S.Email:[emailprotected]Phone: US +1-206-701-6702/UK +44-020 8133 4027

See more here:
Testosterone Replacement Therapy Market Growth Analysis with Top Players Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International...

Testosterone boosters: Uses and effectiveness – Medical News Today

Posted: September 21, 2020 at 3:52 pm

Testosterone boosters include medications and supplements designed to increase testosterone levels in the body. While low testosterone can trigger a range of symptoms, increasing this hormone comes with risks.

In this article, we discuss different types of testosterone boosters and their effectiveness.

Testosterone is an androgen hormone that promotes the development of characteristics people typically associate with masculinity, such as facial hair, deep voice, and muscle growth.

Although testosterone is the principal male sex hormone, it is also present in females, though at much lower levels.

Testosterone influences various aspects of the human body, including:

The normal testosterone value in people varies due to many factors, such as age. The American Urological Association defines low testosterone as less than 300 nanograms per deciliter (ng/dL).

A 2017 study suggests the normal total testosterone range for males aged 1939 years is 264916 ng/dL. The research considers values higher than this as abnormally high.

Low testosterone, or hypogonadism, can occur due to an underlying medical condition, taking certain medications, or injuries to the testes. People may also experience high testosterone levels, typically due to anabolic steroid use, tumors on the adrenal glands, or a medical condition.

A testosterone booster, or testosterone supplement, refers to any natural or artificially produced substance that raises testosterone levels. These may include:

TRT, or androgen replacement therapy, is a medical treatment for low testosterone. It works by replacing the testosterone that the body is not producing. TRT may include:

Injectable testosterone, such as testosterone cypionate (Depo-Testosterone) and testosterone undecanoate (Aveed), contain testosterone esters suspended in oil. Esters are a type of biological compound.

A person can administer this form of testosterone by injecting the solution into the buttocks. People can take these injections every 24 weeks, depending on recommendations from doctors.

Transdermal testosterone includes medicated patches (Androderm) and gels (AndroGel) that people apply directly to the skin.

Androderm patches come in four different strengths: 2 mg, 2.5 mg, 4 mg, or 5 mg of testosterone. The recommended starting dose is one 4 mg patch every 24 hours. A person should apply this to clean, dry skin on the back, thighs, abdomen, or upper arms.

Testosterone gel is available at 1% and 1.62% concentrations. When starting the 1% formulation, a person should apply 50 mg once a day in the morning. The dosage can vary depending on their hormone levels.

Jatenzo is an oral testosterone capsule recently approved by the Food and Drug Administration (FDA) for treating hypogonadism due to underlying medical conditions. The FDA does not recommend Jatenzo for treating age-related low testosterone due to an increased risk of cardiovascular events.

Jatenzo is available in three strengths: 158 mg, 198 mg, and 237 mg. The manufacturers recommend that people start by taking 237 mg twice daily for 1 week. In clinical trials, 87% of participants achieved testosterone levels in the normal range at the end of treatment.

After the first week, a doctor can adjust the dosage according to a persons serum testosterone levels. People should also note that due to a potential increase in blood pressure, Jatenzo may increase the risk of cardiovascular events.

Some supplements may help increase the level of testosterone a persons body produces. These may include:

D-aspartic acid (DAA) is an amino acid that plays a role in creating and releasing several different hormones, including testosterone.

DAA acts on the hypothalamus, triggering an increase of gonadotropin-releasing hormone (GnRH). When GnRH is present, the pituitary gland releases luteinizing hormone (LH), which promotes testosterone production.

Dehydroepiandrosterone (DHEA) is a steroid hormone produced by the adrenal glands. It is a precursor hormone with minimal effects until the body converts it into other hormones, such as estrogen or testosterone.

Due to its effects, DHEA is a popular ingredient in testosterone-boosting supplements.

There are several reasons why a person might use testosterone boosters. These include:

Multiple factors can influence testosterone levels. The body naturally produces less of the hormone with age. In one 2016 study, researchers evaluated the levels of testosterone and DHEA of 271 healthy males between the ages of 4070.

The researchers found testosterone levels decreased by 1.28%, and DHEA decreased by 3.52% each year.

The following factors can lead to low testosterone levels:

TRT is effective in treating low testosterone, but it does not always address the underlying cause. A doctor may recommend lifestyle changes and other medication to treat hypogonadism due to overweight, metabolic disorders, or thyroid problems.

In a 2018 study, researchers coordinated seven controlled trials in 788 older males with low testosterone levels. The participants received either AndroGel 1% or a placebo for 12 months.

The results suggest that testosterone treatment led to moderate improvements in sexual function, bone density, and red blood cell count. Those in the testosterone treatment group showed mild improvements in walking distance, mood, and depressive symptoms.

In a 2017 article, researchers evaluated the efficacy of d-aspartic acid (DAA) reported in 27 animal and human studies.

Findings from the animal studies suggest that DAA increases testosterone levels. However, the human trials produced mixed results. This may be due to limitations of the study design, as well as differences in age, physical fitness levels, and the participants base testosterone levels.

A 2015 study researching the effects of DAA supplementation in 24 males with at least two years of resistance training suggests this technique either showed no significant changes or reduced testosterone levels based on the dosage.

The authors of a 2013 review examined findings from 25 randomized controlled trials that looked at the effects of DHEA supplementation in 1,353 men. The authors conclude it led to minor reductions in body fat, but no improvements in testosterone.

A 2018 review also states there is limited evidence to suggest that DHEA supplementation increases testosterone levels.

Testosterone boosters may provide the following benefits to people with low testosterone levels:

While testosterone replacement may help alleviate the symptoms of hypogonadism, it may not produce the same effects in people with naturally declining testosterone levels.

TRT may lead to the following side effects:

People who inject testosterone may experience pain, swelling, or bruising near the injection site. Topical testosterone gels and patches can also induce allergic reactions at the application site.

The American Urological Association only recommend TRT if a persons testosterone level is below 300 ng/dL, and they show symptoms of hypogonadism. However, the risks of TRT may outweigh its potential benefits.

The FDA does not regulate testosterone supplements, meaning that supplements vary widely in quality, purity, and dosage.

According to the FDA, there is a link between some bodybuilding supplements, as well as products marketed as testosterone alternatives, and the following adverse effects:

Testosterone boosters can help increase a persons testosterone levels. However, their effectiveness will vary based on the type of booster and a persons reasons for taking them.

Testosterone therapy appears to benefit people with conditions such as hypogonadism. However, TRT is usually not recommended to treat age-related declines in testosterone unless managing sexual dysfunction.

More research is necessary to support the use of alternative therapies, such as testosterone supplements. Supplements may also carry some risk of cardiovascular, kidney, and liver disease.

People should always consult a doctor before they start a new medication or supplement.

See more here:
Testosterone boosters: Uses and effectiveness - Medical News Today


Page 517«..1020..516517518519..530540..»